ICD-10-CM Billable Code

M05.1

Rheumatoid lung disease with rheumatoid arthritis

Clinical Classification Guidelines

Medical Intelligence & Overview

Rheumatoid lung disease is a condition that affects the lungs of people who have rheumatoid arthritis, a chronic inflammatory disorder primarily impacting the joints. When rheumatoid arthritis spreads to the lungs, it can cause inflammation, scarring, and other pulmonary issues. Recognized under ICD-10 code M05.1, this disease emphasizes the systemic nature of rheumatoid arthritis beyond joint symptoms, highlighting the importance of comprehensive health care for affected individuals.

Causes & Symptoms

Clinical Causes: Autoimmune response: The immune system mistakenly attacks lung tissue, leading to inflammation and damage. Progression of rheumatoid arthritis: As the disease advances, it can involve organs beyond the joints, including the lungs. Genetic factors: Certain genetic predispositions can increase the risk of developing rheumatoid lung disease. Environmental exposures: Long-term exposure to smoking or pollutants may exacerbate lung involvement in rheumatoid arthritis.

Key Symptoms: Persistent cough that may produce mucus or blood Shortness of breath, especially during exertion Chest pain or discomfort Wheezing or a whistling sound while breathing Fatigue and general weakness Fever and unexplained weight loss in some cases

Diagnostic & Treatment

Diagnosis Path: Chest X-rays to detect lung abnormalities, such as scarring or inflammation High-resolution computed tomography (HRCT) scans for detailed imaging of lung tissue Pulmonary function tests (PFTs) to assess lung capacity and airflow limitations Blood tests to detect markers of inflammation and rheumatoid arthritis activity Biopsy procedures, in certain cases, to confirm tissue involvement Assessment of symptoms and history of rheumatoid arthritis

Treatment Protocols: Medications such as corticosteroids to reduce inflammation Immunosuppressive drugs to modulate the immune response Disease-modifying antirheumatic drugs (DMARDs) to control rheumatoid arthritis activity Oxygen therapy for patients with significant breathing difficulties Pulmonary rehabilitation programs to improve lung capacity and overall well-being Regular monitoring of lung function to track disease progression Addressing environmental factors, such as quitting smoking

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M05.1 a billable ICD-10 code?
Yes, M05.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M05.1?
Clinical documentation must specify the nature of Rheumatoid lung disease with rheumatoid arthritis and any associated comorbidities for accurate reporting.

Cite this Clinical Reference